Azilect is used for treating Parkinson's disease. By inhibiting MAO enzymes, the medication can help increase the amount of dopamine that the brain can use, which can help relieve the symptoms of Parkinson's disease. There are no Azilect uses approved for children, and the drug is not used off-label for other conditions.
Azilect® (rasagiline mesylate) is a Parkinson's disease medication. It belongs to a group of medications known as monoamine oxidase inhibitors (MAOIs). Azilect is taken just once a day and is approved to be used alone or in combination with carbidopa-levodopa medications.
What Is Parkinson's Disease?Parkinson's disease results from the loss of neurons in a region of the brain that controls movement. This creates a shortage of the neurotransmitter (brain-signaling chemical) known as dopamine, causing the movement problems characteristic of Parkinson's disease. The exact cause of Parkinson's disease is not currently known.
Although early symptoms of Parkinson's disease may be subtle, people will eventually develop a characteristic tremor (trembling or shaking) of a limb, especially when the body is at rest. As the disease progresses, symptoms may worsen and new ones may appear.
Depending on the severity of a person's symptoms, Parkinson's disease treatment can include:
- Lifestyle changes and support
- Medications (see Medications for Parkinson's Disease)